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Purpose: The C57BL/6ByJ and BALB/cByJ inbred strains of mice are, respectively, susceptible and resistant to oxygen-
induced retinopathy (OIR). The purpose of this work was to investigate the genetic control of the retinal avascular area
in mouse OIR using a mapping cross.
Methods: The central retinal avascular area was measured on postnatal day 16 (P16) in C57BL/6ByJ, BALB/cByJ, 101
(C57BL/6ByJ x BALB/cByJ)F2, and 116 (BALB/cByJ x C57BL/6ByJ)F2 mice that had been subjected to the OIR
protocol. A genome-wide scan was performed of selected albino and non-albino mice to determine quantitative trait loci
associated with weight and avascular area.
Results: C57BL/6ByJ mice had significantly larger avascular areas than BALB/cByJ ones. Albino mice of the F2
generation had smaller avascular areas than the non-albino mice. Genotyping was performed at 856 informative single
nucleotide polymorphisms approximately evenly distributed across the genome from each of 85 selected F2 mice. Weight,
sex, and the paternal grandmother were found to act as additive covariates associated with the avascular area on P16;
mapping analyses that used a model incorporating these covariates found a quantitative trait locus on chromosome 7
related to avascular area. Mapping analyses that used a model that did not incorporate covariates found a quantitative trait
locus on chromosome 9 related to avascular area. A quantitative trait locus for bodyweight on P16 was mapped to
chromosome 5.
Conclusions: The retinal avascular area in the mouse OIR model is under genetic control. Revascularization in OIR is
related to the weight, strain of paternal grandmother, sex, and albinism. Our data support the existence of a quantitative
trait locus on chromosome 5 that influences weight after exposure to hyperoxia, as well as quantitative trait loci on
chromosomes 7 and 9 that modify susceptibility to OIR.
Retinopathy of prematurity (ROP) is a leading cause of
vision  loss  in  children  in  both  developed  and  developing
countries [1–3]. ROP is a complex disease where disruption
of  normal  developmental  angiogenesis  initially  leads  to  a
persistent avascular phase, which is followed by a phase of
pathological neovascularization. Known risk factors include
the use of supplemental oxygen therapy, low birthweight,
early gestational age at time of birth [4,5], and low serum
levels  of  insulin-like  growth  factor  1  [6]  and  insulin-like
growth factor binding protein 3 (IGFBP3) [7]. Several clinical
investigations have found that rates of severe ROP differ
between ethnic groups even after adjusting for socioeconomic
factors such as access to healthcare, suggesting a heritable
component to ROP development [2,8–10]. Polymorphisms in
the  Wnt  pathway  genes  frizzled-4  (FZD4),  low-density
lipoprotein  receptor-related  protein  5  (LRP5),  and  Norrie
disease protein (NDP) have been associated with individual
cases of severe ROP [11–14]. However, as yet there are no
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genetic factors known to account for a major proportion of
variability in the severity of ROP [10].
Oxygen induced retinopathy (OIR) in the mouse was
developed as a model of ROP [15]. In the mouse OIR model,
exposure  to  hyperoxia  leads  to  central  vaso-obliteration.
When the mice are returned to a normoxic environment, the
region of avascular retina becomes ischemic and creates a pro-
angiogenic  milieu  that  leads  to  retinal  neovascularization
[15,16].  The  hyperoxic  phase  of  OIR  creates  conditions
somewhat similar to those created in the past by overuse of
O2 in the treatment of premature infants. However, hyperoxia
in  the  OIR  model  leads  to  obliteration  of  central  retinal
vessels, while ROP results from the failure of vascularization
of the peripheral retina. The neovascular phases of OIR and
ROP  are  broadly  analogous.  When  mice  that  have  been
exposed  to  hyperoxia  in  the  OIR  model  are  returned  to
normoxia, the retina gradually revascularizes with vessels that
appear anatomically normal. The initial stages of vascular
regeneration are seen before pathological neovascular tufts
become evident. The study of the revascularization phase of
OIR may be pertinent to understanding retinal angiogenesis
in  the  preproliferative  phase  of  ROP.  For  example,  a
demonstration  that  exogenous  IGFBP3  increased  vessel
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377regrowth in OIR was followed by the observation that serum
IGFBP3 correlated with less severe ROP in humans [7].
Interstrain differences in response to OIR models have
been investigated in both mice and rats. Van Wijngaarden
[17] demonstrated that pigmentation status is associated with
the retinal avascular area in crosses between the Fischer 344
and Dark Agouti rat strains. In crosses between these two
strains, retinas from albino animals exposed to OIR were
found to express lower levels of erythropoietin than retinas
from  pigmented  animals.  In  further  work  [18],  van
Wijngaarden  found  that  OIR-susceptible  rat  strains
demonstrated  reduced  expression  of  angiogenesis-related
genes in early retinal development than did OIR-resistant rats,
but higher expression of these genes in the proliferative phase
of OIR. Chan et al. [19] performed a similar study comparing
gene expression in retinas of different mouse strains exposed
to the OIR model. Dorrel et al. [20] have shown that the
astrocytes in the retinas of C57BL/6J mice exposed to the OIR
protocol,  unlike  the  astrocytes  of  BALB/c  mice,  quickly
degenerate after the mice are returned to normoxia. Although
these strain-specific differences have been found, no previous
study has employed a genome-wide approach to investigate
genetic differences that modify OIR.
This study uses a known difference between BALB/cByJ
and C57BL/6ByJ mice to investigate the genetics of control
of the extent of avascular areas measured four days after
returning to normoxia. These strains were used in a mapping
cross designed to identify quantitative trait loci (QTL) that
modify this phenotype. Since C57BL/6 mice exposed to the
OIR  model  develop  more  severe  neovascularization,  and
revascularize  more  slowly,  than  BALB/c  mice—despite
having  similar  vaso-obliterative  responses  [20]—the
phenotype of the avascular area measured four days after
returning to normoxia is likely to be largely a measure of the
rate of vascular regrowth.
METHODS
Animals: All experimental procedures were approved by the
University of Kansas Medical Center Institutional Animal
Care and Use Committee. BALB/cByJ and C57BL/6ByJ mice
were purchased from Jackson Laboratories (Bar Harbor, ME).
All mice were kept in a 12 h:12 h light-dark cycle with ambient
room temperature between 19 °C and 22 °C. Mice were kept
on a standard diet (8604 rodent diet; Harlan Laboratories,
Indianapolis, IN), and breeding pairs were maintained on a
higher-fat diet (8626 rodent diet; Harlan Laboratories), with
chow and water available ad libitum.
An F2 intercross population was bred using reciprocal
mating strategies (Figure 1). Phenotypes were obtained from
116 (BALB/cByJ x C57BL/6ByJ) F2 and 101 (C57BL/6ByJ
x  BALB/cByJ)  F2  mice.  Values  were  also  obtained  from
BALB/cByJ  and  C57BL/6ByJ  mice  to  confirm  their
differential susceptibility to OIR.
Avascular areas in OIR: OIR was induced by exposing pups
to  75%  oxygen  beginning  on  P7  and  returning  them  to
normoxia  after  120  h.  O2  levels  in  the  chambers  were
continuously  controlled  using  a  ProOx  portable  monitor
(Biospherix, Redfield, NY), which was calibrated monthly
using room air and 100% O2. Retinas were analyzed 96 h after
their  return  to  hypoxia,  since  previous  unpublished
observations  had  suggested  that  at  this  time  point  the
interstrain differences were greatest. This experimental plan
allowed  genetic  modifiers  of  vascular  regeneration  to  be
investigated. On postnatal day 16 (P16), mice were weighed,
anesthetized with a lethal dose of tribromoethanol delivered
by  intraperitoneal  injection,  perfused  with  high-molecular
Figure  1.  Illustration  of  the  breeding
scheme used in the mapping cross. The
BALB/cByJ and C57BL/6ByJ parental
strains are crossed in both directions.
The resulting F1 mice are inbred through
brother–sister mating to produce the F2
generation.  This  figure  shows  the
manner in which the Y chromosomes
and  recombined  (black  and  white-
striped) and unrecombined (solid color)
X chromosomes are passed through the
generations  of  the  cross.  White
chromosomes  are  inherited  from  the
BALB/cByJ  albino  parent,  and  black
chromosomes  are  inherited  from  the
C57BL/6ByJ  pigmented  parent.  The
different  coat  colors  shown  in  the  F2
generation are for illustrative purposes
only.  The  color  of  the  F2  animals  is
unrelated  to  either  gender  or  the
direction of the cross.
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378weight  fluorescein  isothiocyanate-labeled  dextran
(MW≥2,000,000; Sigma, St. Louis, MO) via the left ventricle
to visualize patent vessels, and then enucleated. Tail samples
were taken and stored at −20 °C, and the sex was documented.
Retinas were fixed overnight in 4% paraformaldehyde at
4  °C,  dissected,  and  flatmounted  using  antifade  medium
(Southern Biotech). Immunofluorescent micrographic images
of the retinas were taken using an SMZ 1500 microscope
(Nikon, Tokyo, Japan) and MagnaFire Camera and software
(Optronics,  Goleta,  CA).  ImageJ  software  was  used  to
manually  trace  and  measure  nonperfused  areas.  A  mean
avascular area was calculated for each mouse using data from
left and right eyes.
DNA preparation and genotype analysis:
Genotyping  strategy—Selective  genotyping  methods
that decrease the cost of genotyping with only minor loss of
information [21–23] were used. For the purpose of selecting
the mice to genotype, the avascular area was adjusted for the
weight of the animals to account for the effect of weight on
the response to OIR. To do this, a correlation coefficient of
−0.1743 mm2/g was determined using linear regression and
multiplied by the weight to create an adjustment factor for
each  mouse.  Since  a  significant  difference  was  observed
between the avascular areas of albino and non-albino mice,
these groups were considered separately when choosing mice
to  genotype.  A  group  of  mice  with  the  smallest  adjusted
avascular areas (11 albino and 32 non-albino mice) and a
group with the largest adjusted areas (11 albino and 32 non-
albino mice) were chosen for genotyping.
DNA preparation—DNA was extracted from 0.5 cm
mouse tail samples using the DNEasy Blood and Tissue Kit
(Qiagen, Valencia, CA); concentration and purity (absorbance
ratio at 260/280 nm) were determined using a NanoDrop-1000
spectrophotometer (ThermoFisher Scientific, Waltham, MA).
DNA samples were diluted to 25–150 ng/µl.
Genotype  analysis—Genotyping  services  were
provided by the Center for Inherited Disease Research (Johns
Hopkins University, Baltimore, MD) using a standard linkage
panel  containing  856  informative  autosomal  and  X
chromosomal  single  nucleotide  polymorphisms  (SNPs;
Mouse Medium Density Linkage Panel; Illumina, San Diego,
CA). For each chromosome, except chromosome X, the most
proximal  marker  genotyped  was  within  13.4  Mb  of  the
centromere; on chromosome X, the most proximal marker was
at 33.5 Mb from the centromere. The most distal marker was
within 5.8 Mb of the telomere for all chromosomes. Internal
markers  were  no  more  than  24.6  Mb  from  each  other
(chromosome  1),  except  on  chromosome  2,  where  two
markers  were  spaced  64.4  Mb  apart.  Mean  spacing  was
approximately 7.88 Mb between markers. Physical distances
quoted in this paper were taken from mouse genome build
37.2, and SNP data were taken from dbSNP Build 128. DNA
samples from each parental strain and one F1 mouse produced
from  each  direction  were  used  as  control  samples.  Data-
checking analyses suggested by Broman et al. [24] were run
before mapping analysis to ensure the quality and integrity of
both phenotype and genotype data. Due to inconsistencies in
the genotyping results, an albino female mouse from the low
avascular area group was excluded from subsequent analysis.
The genotype of the tyrosinase locus of the mice not
selected for genotyping was inferred from coat color. In this
cross,  albinism  was  conferred  by  homozygosity  for  the
BALB/c allele of tyrosinase. The genotype of albino mice at
the tyrosinase locus was encoded as AB/cAB/c. For all non-
albino mice, a code indicating “not-AB/cAB/c” was used.
QTL mapping, identification of covariates: Coat color, sex,
pigmentation and the strain of the paternal grandmother were
tested using ANOVA (ANOVA) models to identify traits
associated with the primary phenotypes of interest (weight
and unadjusted avascular areas). The inclusion of covariates
in mapping analyses reduces residual variation and enhances
QTL detection [24]. Any variable found to have a statistically
significant association was included in mapping models, as
described below.
Linkage  analysis:  The  data  were  analyzed  using  R/qtl
software [25]. Initial linkage analysis was performed using
standard interval mapping to determine a logarithm of odds
(LOD) score correlating the genotype with the phenotype for
each marker. The weight and unadjusted avascular area were
analyzed separately as primary phenotypes. Analyses were
also  performed  using  the  sex,  paternal  grandmother,
pigmentation, and weight as covariates. All covariates were
compared as additive and interactive covariates in separate
models to determine the best fit. To account for the multiple
testing inherent in genome-wide QTL studies, and to control
the type I error rate such that the probability of a false positive
over all tests is below some value, significance thresholds
were determined empirically via permutation testing [26]. We
estimated the experiment-wise significance thresholds using
1,000  permutations  for  each  data  set,  defining  the  LOD
thresholds  for  highly-significant  QTL  (at  p<0.05)  and
significant  QTL  (at  p<0.1).  One  thousand  permutation
replicates  has  been  shown  to  be  an  adequate  number  for
estimating critical thresholds [26], and is the number routinely
employed in QTL mapping studies.
Gene–gene  interactions:  Secondary  analyses  included
composite interval mapping to determine influence of markers
near  QTL  on  other  loci  (i.e.,  gene–gene  interactions).
Additionally,  two  dimensional,  two-QTL  scans  were
performed to consider linked or interacting QTL.
Estimating QTL effects: To estimate the contribution of QTL
identified  in  the  linkage  analysis,  the  allelic  effects  were
calculated  and  compared  between  mice  categorized  by
genotype  (AB/cAB/c,  AB/cAC57,  AC57AC57).  Additive  and
dominance effects were also considered in calculations. The
QTL effects were assumed to correspond to the SNP marker
nearest the peak LOD score.
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379RESULTS
Differences in response to OIR between strains: To confirm
the response of parental strains to the OIR model, 15 BALB/
cByJ offspring from three litters and ten C57BL/6ByJ mice
from three litters were exposed to hyperoxia, as described.
Typical flatmounted fluorescein dextran-perfused retinas are
shown  in  Figure  2.  The  measurement  of  mean  retinal
avascular areas on P16 showed C57BL/6ByJ mice to have a
2.9 fold greater unadjusted area than had the BALB/cByJ mice
(1.55  mm2  versus  0.53  mm2,  Welch’s  two-sample  t-test,
p<0.0005).
Weight ranged from 4.15 to 10.95 g. BALB/cByJ mice
weighed more on P16 than did their C57BL/6ByJ counterparts
(with  means  of  7.64  and  6.05  g,  respectively,  ANOVA,
p=0.009).  After  adjusting  avascular  areas  for  weight,  as
described above, the C57BL/6ByJ mice were still found to
have  greater  avascular  areas  than  had  BALB/cByJ  mice
(2.60 mm2 versus 1.86 mm2, ANOVA, p=0.0002, Figure 3),
suggesting that the difference in avascular area was not due
to differences in weight alone.
No differences in unadjusted avascular areas were found
between male and female mice, either within each strain or
across strains (ANOVA, BALB/cByJ, p=0.4, C57BL/6ByJ,
p=0.5; Student’s t-test, all mice: p=0.06). The same was true
when  comparing  adjusted  avascular  area  between  mouse
genders  (ANOVA,  BALB/cByJ,  p=0.07,  C57BL/6ByJ,
p=0.15; Student’s t-test, all mice: p=0.08).
Effect of covariates on phenotypes in F2 population: On P16,
weight was investigated as a primary phenotype to identify
potential  QTL  related  to  body  mass.  ANOVA  tests  were
performed  to  investigate  the  correlation  of  secondary
phenotypes  with  weight,  but  no  statistically  significant
association between weight and the sex, strain of the paternal
grandmother, or coat color was found.
Figure 2. Retinas after oxygen induced
retinopathy  (OIR)  protocol.  A:
Flatmounted  retina  of  a  BALB/cByJ
mouse  on  postnatal  day  16  after
exposure to the OIR protocol. The retina
is  relatively  well  vascularized  at  this
time point. B: A retina from a C57BL/
6ByJ mouse at the same time point after
exposure  to  the  OIR  protocol.  The
central  retina  has  large  areas  of
avascularity.
Figure  3.  Mean  avascular  areas  of
parental  strains  after  adjusting  for
influence of weight. This shows that the
BALB/cByJ strain has smaller areas of
avascular  retina  in  response  to
hyperoxia than the C57BL/6ByJ strain
(ANOVA, p=0.0002).
Molecular Vision 2012; 18:377-389 <http://www.molvis.org/molvis/v18/a41> © 2012 Molecular Vision
380F2 mice had unadjusted avascular areas ranging from
0.013 to 2.76 mm2, with a mean of 1.06 mm2. On P16, their
mean weight was 6.70 g, with a range from 3.56 to 11.77 g.
Linear regression analysis showed that the avascular area was
inversely associated with weight (ANOVA, p<10−8, Figure 4).
Coat  color  pigmentation  correlated  with  the  adjusted
retinal avascular area. Albino F2 mice exposed to the OIR
model  had  smaller  adjusted  avascular  areas  than  had
pigmented  mice  (ANOVA,  p<5×10−8,  Figure  5).  No
associations  between  the  avascular  area  and  any  of  the
individual  non-albino  coat  colors  were  found  (ANOVA,
p=0.39).
The strain of the paternal grandmother was associated
with an adjusted avascular area in the F2 generation (ANOVA,
p=0.004). F2 mice produced from inbreeding (BALB/cByJ x
C57BL/6ByJ)F1 parents had smaller avascular areas than had
those produced from the reciprocal cross (2.12 mm2 versus
2.34 mm2). The paternal grandmother was included in the
mapping analysis as an additive covariate. Segregating F2
mice by both the paternal grandmother and sex did not show
any statistically significant differences (ANOVA, p=0.41),
suggesting that the two covariates did not interact.
In the F2 mice, unlike in the parental generation, gender
was associated with the avascular area (the avascular area was
2.16 mm2 for males, 2.28 mm2 for females, ANOVA, p=0.02).
Gender  was  not  found  to  interact  with  other  secondary
phenotypes  such  as  weight,  coat  color,  or  the  paternal
grandmother (ANOVA, p=0.08, 0.52, and 0.40, respectively)
in the F2 generation.
ANOVA testing of the weight, paternal grandmother, and
sex  did  not  show  any  statistically  significant  interaction
between  the  covariates  (p>0.05).  Therefore,  they  were
included as additive covariates in mapping analyses.
On  P16,  analyses  were  performed  to  identify  QTL
potentially related to body mass. ANOVA tests were run to
consider the candidacy of secondary phenotypes as covariates,
but no statistically significant associations between the weight
and the sex, strain of the paternal grandmother, or coat color
were found.
Identification of QTL related to OIR response:
Mapping  without  covariate  inclusion—The  initial
QTL analysis employed a covariate-free model. This analysis
identified two LOD score peaks associated with avascular
areas  that  reached  the  genome-wide  threshold  of  α=0.05.
These peaks occurred on chromosomes 7 and 9 (Table 1,
Figure 6A). On chromosome 9, the peak LOD score (3.75,
p=0.05, Figure 6B) occurred at SNP rs4135590, located 42.8
Mb distal from the centromere. The genotype at this QTL
explained 6.5% of the variance in avascular areas (p=0.0007,
Table 1), with each BALB/cByJ allele having an additive
protective effect (Figure 6C). The 1.8-LOD support interval
was found to be 12.4–96.0 Mb distal from the centromere.
Figure  4.  The  inverse  association
between avascular area and weight of
F2  mice  at  postnatal  day  16  after
exposure  to  oxygen-induced
retinopathy.  The  avascular  area  was
shown to correlate with weight with a
coefficient of −0.1743. This association
was shown to be statistically significant
(Welch’s two-sample t-test, p<10−8).
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381The  peak  on  chromosome  7  was  located  at  SNP
rs13479427, 107.2 Mb distal from the centromere. The LOD
score  of  this  peak  was  8.90  (p<0.004).  The  QTL  on
chromosome 7 explained 17.5% of the phenotypic variance
(Table 1, p<0.004). At this locus, the BALB/cByJ allele had
a recessive protective effect. A 1.8-LOD support interval was
determined to lie 81.2–146.5 Mbp distal from the centromere.
The marker at 146.5 Mbp was the most telomeric marker
included in the SNP panel, therefore we are unable to exclude
the possibility that the support interval extends as far as the
telomere.
A two-QTL model including the peaks on chromosome
7  and  9  found  that  these  loci  explained  23.2%  of  the
phenotypic variance (p=1.8×10−11), with a combined LOD
score of 12.4.
Mapping with covariates—Using weight, the strain of
the paternal grandmother, and sex as additive covariates, a
single  LOD  score  peak  associated  with  the  unadjusted
avascular area was identified on chromosome 7 at a genome-
wide threshold of α=0.05 (Table 1, Figure 6D). This QTL is
located  at  134.2  Mb,  between  SNPs  rs13479506  and
CEL-7_115892950. The LOD score of this peak was 9.83
(p<0.004). The QTL on chromosome 7, in conjunction with
the covariates, explained 34.2% of the phenotypic variance
(Table 1, p<0.004). At this locus, the BALB/cByJ allele had
an  additive  protective  effect  (Figure  6E).  The  1.8-LOD
support interval was calculated to extend from 88.2 to 146.2
Mb distal from the centromere. The distal boundary of this
interval  coincided  with  the  most  distal  marker  tested.
Therefore, it is possible that if a marker at the telomere had
been  tested,  it  would  have  been  found  that  the  interval
extended as far as the telomere.
Locus–locus interactions: Composite interval mapping was
conducted  using  the  genotype  at  the  putative  QTL  on
chromosome 7 as an additive or interactive covariate with
other loci; this model reduced residual variation to clarify
evidence for further QTL, allowing detection of background
loci with weak main effects [24]. No additional loci were
Figure 5. Comparison of avascular areas
for albino and non-albino F2 mice. The
mean avascular area of albino mice was
found to be 0.67 mm2 versus 1.20 mm2
for  non-albino  mice,  a  statistically
significant  difference  (ANOVA,
p<0.0001).
TABLE 1. QTL ASSOCIATED WITH RETINAL AVASCULAR AREA IN OXYGEN INDUCED RETINOPATHY
Significance Chromosome Phenotype LOD
Score
Markers at or flanking
QTL
Marker
position
(Mb)
LOD support interval (Mb) Effect on
Phenotype
p<0.004 7 Avascular area
(P16)
8.90† rs13479427 107.2
131.8
81.2 – 146.5 0.175
      9.83* rs13479506
CEL-7_115892950‡
135.8 88.2 – 146.5 0.342
p=0.05 9 Avascular area
(P16)
3.75† rs4135590 42.8 12.4 – 96.0 0.065
p=0.05 5 Weight (P16) 3.91† CEL-5_93945748 97.1 52.8 – 133.6 0.041
        † mapping analysis excluded covariates; * mapping analysis included weight, sex, and paternal grandmother as covariates. 
        ‡ the two markers flanking the LOD score peak are reported.
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382discovered.  A  two-dimensional,  two-QTL  scan  was
conducted  to  identify  any  epistatic  interactions.  No
statistically significant linked or multiple QTL were found.
Identification of a QTL related to weight: Standard interval
mapping identified an LOD score peak on chromosome 5 that
reached  the  genome-wide  threshold  for  high  significance
(α=0.05,  as  determined  by  permutation  tests).  The  peak
occurred at the SNP CEL-5_9395748, approximately 97.1 Mb
distal from the centromere (LOD=3.91, p=0.024, Figure 7).
On P16, at this locus, the C57BL/6ByJ allele was found to be
associated with greater weight in a dominant fashion. Using
this  single-QTL  model,  the  genotype  at  this  locus  was
estimated to explain 4.1% of the variance in weight (p=0.01).
A 1.8-LOD support interval was derived using an algorithm
in R/qtl by interpolating between markers on the basis of
recombination frequency, and was found to be 52.8–133.6 Mb
distal from the centromere.
Identification of candidate genes: A list of candidate genes
located within the 1.8-LOD support intervals for the QTL was
created using a web-based virtual positional cloning program,
Positional Medline Database [27], queried March 15, 2011.
The program identifies candidate genes for the LOD support
interval of putative QTL related to keywords. The search
region on chromosome 7 was extended to the telomere (152
Figure 6. The results of genetic linkage
mapping using central retinal avascular
area as the phenotype. A: Linkage map
of  avascular  area  across  the  whole
genome  created  using  no  covariates
(blue)  and  using  weight,  paternal
grandmother,  and  sex  as  additive
covariates  in  the  analysis  (red).
Empirically  derived  genome-wide
(alpha=0.05) thresholds of significance
are  shown  as  horizontal  lines.  For
mapping  without  covariates  the
threshold  of  significance  was  a
logarithm of odds (LOD) score of 3.75.
For  mapping  with  covariates  the
threshold of significance LOD score of
3.81.  Mapping  without  covariates
identified  peaks  on  chromosomes  7
(LOD=8.90)  and  9  (LOD=3.75).
Mapping  with  covariates  identifed  a
peak  on  chromosome  7  (LOD=9.83).
B: Linkage map of avascular area across
chromosome  9  created  without
inclusion of covariates, showing a peak
at SNP rs4135590 (LOD=3.75, p=0.05).
C:  Effect  plots  of  primary  peak  on
chromosome  9.  The  BALB/cByJ
allelotype was found to be additively
protective against the development of
OIR. D: Linkage map of avascular area
across  chromosome  7  created  by
including weight, paternal grandmother,
and sex as additive covariates, showing
a peak between SNPs rs13479506 and
CEL-7_115892950  (LOD=9.83,
p<0.004). E: Effect plot of the peak on
chromosome  7  at  the  nearest  marker,
CEL-7_115892950.  The  BALB/cByJ
allelotype at this locus is shown to have
a protective effect in a recessive manner.
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383Mb); 160 candidate genes were identified in this interval using
“retina AND angiogenesis” as keywords in the query. The ten
genes most-correlated with the search terms were mitogen
activated protein kinase 3 (Mapk3), antigen KI-67 (Mki67),
fibroblast growth factor 4 (Fgf4), fibroblast growth factor
receptor 2 (Fgfr2), insulin-like growth factor 2 (Igf2), tyrosine
hydroxylase (Th), fibroblast growth factor 3 (Fgf3), extra
cellular link domain-containing 1 (Xlkd1), BCL2/adenovirus
E1B interacting protein 3 (Bnip3), and cyclin D1 (Ccnd1).
Using “oxidative stress” as keywords in the query over the
same interval to identify potential candidate genes related
specifically  to  vaso-obliteration,  Positional  Medline
identified  231  genes;  the  top  ten  included:  Mapk3,  Th,
Mki67, cytochrome P450 2E1 (Cyp2e1), amyloid beta A4
(Apbb1),  parathyroid  hormone  (Pth),  integrin  alpha  M
(Itgam), integrin alpha L (Itgal), integrin-linked kinase (Ilk),
and Igf2. Twenty-five genes were found within the support
interval of the QTL on chromosome 9 using “retina AND
angiogenesis,”  including  alpha  disintegrin  and
metallopeptidase domain 10 (Adam10), chondroitin sulfate
proteoglycan  4  (Cspg4),  alpha  crystallin  B  (Cryab),
sphingosine-1-phosphate receptor 2 (Edg5), Pbx/knotted 1
homeobox  2  (Pknox2),  erythropoietin  receptor  (Epor),
dopamine receptor 2 (Drd2), heat shock protein 2 (Hspa2),
cytochrome  P450  family  1  subfamily  a  polypeptide  2
(Hspb2), cytochrome P450 family 1 subfamily a polypeptide
2  (Cyp1a2),  and  cytochrome  P450  family  1  subfamily  a
polypeptide  1  (Cyp1a1);  “oxidative  stress”  identified  246
candidates,  including  kelch-like  ECH-associated  protein  1
(Keap1), apolipoprotein A-I (Apoa1), beta-site APP cleaving
enzyme 1 (Bace1), Drd2, low density lipoprotein receptor
(Ldlr), intercellular adhesion molecule 1 (Icam1), cytochrome
P450  family  19  subfamily  a  polypeptide  1  (Cyp19a1),
amyloid beta (A4) precursor-like protein 2 (Aplp2), Cyp1a2
and Cyp1a1. For the support interval found on chromosome
5 using weight as the primary phenotype, “birth weight” was
used as the keyword in the query to derive 101 candidate
genes,  including  scavenger  receptor  class  B,  member  1
(Scarb1), alpha fetoprotein (Afp), group specific component
(Gc), chemokine (C-X-C motif) ligand 2 (Cxcl2), heparanase
(Hpse), chemokine (C-X-C motif) ligand 1 (Cxcl1), casein
beta (Csn2), amphiregulin (Areg), platelet factor 4 (Pf4 or
Cxcl4), and chemokine (C-X-C motif) ligand 10 (Cxcl10).
DISCUSSION
ROP remains a significant cause of vision loss in the pediatric
population. Although some risk factors have been identified,
its development is complex and involves both environmental
and  genetic  factors.  This  study  aimed  to  initiate  the
identification  of  genes  that  may  play  a  role  in  ROP
Figure 7. The results of genetic linkage
mapping using bodyweight 96 h after
exposure to hyperoxia as the phenotype.
A:  A  genome-wide  linkage  map  of
weight  on  postnatal  day  16  after
exposure  to  the  oxygen-induced
retinopathy  model.  The  threshold  of
significance  was  found  to  be  3.86
(α=0.05), as determined by permutation
tests.  B:  Shows  linkage  across
chromosome 5, with significant linkage
at  marker  CEl-5_93945748
(LOD=3.91, p=0.024). C: Effect plot of
genotypes at this marker on postnatal
day 16; homozygosity for the BALB/
cBJ allelotype at this locus is associated
with  reduced  weight  in  a  recessive
manner  (ANOVA,  p<0.001).  The
BALB/cByJ  allele  is  designated  AB/c,
and  the  C57BL/6ByJ  alleles  is
designated AC57.
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384susceptibility. Using the murine OIR model, we developed a
mapping cross between C57BL/6ByJ and BALB/cByJ inbred
mouse  strains.  These  mice  were  confirmed  to  have
significantly different vascular responses to OIR on P16, with
the BALB/cByJ strain having smaller avascular areas than the
C57BL/6ByJ strain. These results support those published by
Dorrell, et al. [20], which found that while both strains have
similar vaso-obliterative areas upon their return to normoxia
on P12, the BALB/cByJ strain revascularizes more rapidly
than the C57BL/6J strain.
Genetically  determined  differences  in  retinal  ocular
morphology between the two strains may play a role in their
responses to OIR. Recent reports using confocal scanning
laser ophthalmoloscopy confirm physiologic differences in
retinal structure between adult C57BL/6J and BALB/c mice,
with BALB/c mice having significantly thinner central retinas
(211  μm  versus  237  μm)  [28].  The  differences  between
C57BL/6J and BALB/c mice are at least partially related to
C57BL/6J  being  a  pigmented  strain,  while  BALB/c  is  an
albino strain [29–31], and this issue is discussed further below.
The  mapping  cross  revealed  QTL  associated  with
susceptibility to OIR on chromosomes 7 and 9. The BALB/
cByJ  allele  of  the  chromosome  7  QTL  was  found  to  be
protective in a recessive manner. In a mapping model that
includes weight, sex, and the paternal grandmother as additive
covariates, the allelotype at this marker is estimated to explain
34% of the phenotypic variation. The BALB/cByJ allele of
the chromosome 9 QTL was also found to be protective in a
recessive  manner;  this  peak  only  reached  statistical
significance when covariates were excluded from the model.
In a single QTL model, this allele was estimated to explain
7% of the variation in phenotype.
No QTL was identified on the X chromosome, despite
evidence  that  the  strain  of  the  paternal  grandmother  was
associated with the avascular area. It was noted that when
initially performing mapping analyses with single covariates
to confirm their inclusion in the final model, the inclusion of
the paternal grandmother alone caused a loss of the peak on
chromosome 9. This suggests that the directionality of the
cross may influence susceptibility via an epigenetic effect on
a  gene  or  genes  within  this  locus,  rather  than  through  a
modifier gene on the X chromosome.
A  QTL  related  to  weight  on  P16  was  identified  on
chromosome  5.  The  C57BL/6ByJ  allele  was  found  to  be
associated with greater weight in a dominant manner; the
genotype at this locus was estimated to explain 4.1% of the
variance in weight at this time point. The selective genotyping
model based on avascular area, rather than weight, may have
introduced bias in estimating the effect of this QTL on weight
and avascular area. In both human ROP and murine OIR,
increased  birthweight  and  subsequent  weight  gain  are
protective  against  neovascularization  [32,33];  although
C57BL/6ByJ mice had larger avascular areas on P16 than had
their  BALB/cByJ  counterparts,  the  data  suggest  that  the
C57BL/6ByJ genome does contain an allele related to weight
that serves to protect against OIR.
The  initial  analysis  of  F2  mice  revealed  significantly
different retinal avascular areas in albino and non-albino mice.
This result supports findings from a rat backcross [17] as well
as across different strains of rats [34]. Because albinism in this
cross  is  caused  by  the  homozygous  loss  of  function  of
tyrosinase, the rate-limiting enzyme in the biosynthesis of
melanin [31], these data suggest that tyrosinase or a linked
gene might play a role in disease susceptibility. The QTL
identified on chromosome 7 by mapping analysis includes
tyrosinase (located at 94.58–94.64 Mb) within the 1.8-LOD
support interval. An intriguing possibility is that tyrosinase
itself is a modifier of the area of the avascular retina in rodent
OIR.
The  tyrosinase  gene  has  various  roles  in  ocular
physiology. There are numerous morphological differences
between the retinas of albino and non-albino mice, and it is
not clear whether these may be associated with responses to
hyperoxia.  It  is  possible  that  the  thicker  C57BL/6  retina
becomes more hypoxic than the BALB/c retina, and that this
leads  to  greater  astrocyte  degeneration  and  slower
revascularization  [29–31].  The  absence  of  melanin  in  the
retinal pigment epithelium may alter the response of the retina
to oxidative stress [17]. Alternatively, since the absence of
melanin in the iris increases the amount of light reaching the
retina [35], it is possible that greater retinal light exposure
affects the revascularization process, even though light has
not previously been demonstrated to play a role in modifying
the severity of OIR [36]. Furthermore, tyrosinase can form
L-3,4-dihydroxyphenylalanine  (L-dopa),  the  immediate
precursor of dopamine [37]. The role of dopamine metabolism
in  OIR  is  currently  unknown,  but  dopamine  is  known  to
modulate tumor angiogenesis [38], and may play a role in
angiogenesis in OIR. Since albinism interacts with retinal
physiology  in  many  ways,  we  are  performing  further
experiments  to  investigate  the  candidacy  of  tyrosinase.
However, neither our experiment nor the work that found an
association  between  albinism  and  OIR  in  rats  [17]  were
designed to test the candidacy of any particular gene.
Positional Medline identified several other interesting
candidate genes, located within the support interval of the
QTL on chromosome 7, using the keywords “retina AND
angiogenesis.” MAPK3, or ERK-1, is a mitogen-activated
kinase that is activated by fibroblast growth factor (FGF) to
induce endothelial cell proliferation in retinal angiogenesis
[39], and has been shown to play a role in regulating VEGF
expression  in  response  to  oxidative  stress  [40].  FGF4,  a
member of the FGF family, is a mitogen that is involved in
the development and morphogenesis of various cell and tissue
types [41]. Overexpression of FGFR2, a receptor for FGF, has
been demonstrated in several types of neoplasia, including
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385breast cancer [42], prostate cancer [42], renal cell carcinoma
[43], and gastric cancer [44]. Within the retina, insulin-like
growth  factor  2  is  present  almost  exclusively  in  the
photoreceptors and vasculature, where it is the major locally
expressed growth factor. However, it is not expressed in the
vascular endothelial cells in the neovascular tufts formed in
response to OIR [45]. Tyrosine hydroxylase is the enzyme
primarily responsible for dopamine production in the central
nervous system and retina; in the eye, it is found primarily in
amacrine cells in the inner plexiform layer [46]. Xlkd1, or
extra-cellular link domain containing 1, encodes a hyaluronan
receptor expressed on the lymphatic endothelium in both adult
and  embryonic  vessels,  and  XLKD1-positive  cells  were
recently  identified  in  the  hyaloid  vascular  system  of  the
developing murine eye [47].
Four of the top ten putative genes identified by using the
key terms “oxidative stress” (Mapk3, Th, Mki67, and Igf2)
were also identified in the prior search. Integrin alphas L, and
M (CD11a and b, respectively) are expressed on neutrophils,
and when complexed with beta-2 integrin CD18, function to
modulate the migration of the cells to the site of the injury by
binding  intracellular  adhesion  molecule  1  (ICAM1)  on
endothelial cells [48]. VEGF-A has been shown to stimulate
neutrophil and T-cell recruitment in an ITGAL- and ITGAM-
dependent  manner  [49].  Integrin-linked  kinase  (ILK)-
signaling has been shown to mediate the production of the
brain-derived neurotrophic factor by endothelial cells [50],
and oxidative stress disrupts this signaling pathway [51].
Although ranked less highly by the Positional Medline
algorithm, three genes related to Wnt signaling pathways were
included in the list of candidate genes. Wnt signaling plays an
essential role in cell survival, proliferation, and migration, and
has  an  important  role  in  controlling  both  developmental
retinal angiogenesis and retinal neovascularization in disease
states [52]. Mutations in genes related to this pathway have
been implicated in several ocular neovascular diseases with
phenotypic similarities to ROP, including familial exudative
vitreoretinopathy and Norrie disease [53]. Frizzled-4 (FZD4)
is  a  Wnt  receptor  that  functions  in  both  canonical  and
noncanonical signaling pathways. Mutations in FZD4 have
been  identified  as  a  cause  of  familial  exudative
vitreoretinopathy  [54]  and  have  been  confirmed  in  cases
worldwide [55,56]. More recently, FZD4 mutations have been
found in a small number (3%) of a cohort of infants with severe
ROP [11]. Interestingly, the mouse Fzd4 gene lies within the
QTL found on chromosome 7. Wnt11 is another gene involved
in  Wnt  signaling  that  is  encoded  within  the  QTL  on
chromosome  7;  WNT11  is  a  noncanonical  ligand  in  the
pathway. Within the retina specifically, mutations in Wnt11
have  been  shown  to  result  in  increased  angiogenesis  and
branching [57]. Dickkopf 3 (DKK3) belongs to a family of
secreted glycoproteins that act as regulators of Wnt signaling.
In the retina, Dkk3 is expressed by Müller glia and retinal
ganglion cells, and is a cell type-specific positive regulator of
Wnt signaling. In response to photoreceptor death in a murine
model  of  retinal  degeneration,  Dkk3  expression  was
upregulated, and functioned to inhibit caspase activation in
Müller glia [58].
The LOD support interval on chromosome 9 also contains
several  interesting  candidates  identified  by  Positional
Medline, related to the retina and angiogenesis. Chondroitin
sulfate  proteoglycan  4  (CSPG4),  also  known  as  NG2,  is
expressed by nascent pericytes early in angiogenesis. Studies
of ischemic retinal neovascularization have shown decreased
ectopic  vessel  protrusion  into  the  vitreous,  and  decreased
proliferation of both pericytes and endothelial cells in NG2
knockout (KO) mice [59]. Similarly to MAPK3, MAP2K1
(MEK1)  mediates  FGF-stimulated  endothelial-cell
proliferation in tumor models [39]. IL18 has been shown to
play  a  role  in  regulating  the  regression  of  pathological
neovascularization in mice after their exposure to the OIR
model [60]; additional studies using KO mice suggest that
IL18 plays a role in regulation of retinal vessel formation
[61]. Crystalline alpha B is a chaperone within the small heat-
shock protein family and has been shown, using KO mouse
models, to play a role in intraocular angiogenesis by acting as
a chaperone for VEGF-A [62]. Erythropoietin (EPO) has been
linked to both ROP and diabetic retinopathy. Local tissue EPO
levels are suppressed during retinal vessel loss in OIR and
elevated during neovascularization, and the pharmacological
use  of  EPO  has  been  shown  to  protect  against  hypoxia-
induced  apoptosis  [63].  The  siRNA  inhibition  of  EPO
expression during the neovascular phase of OIR has been
shown to inhibit neovascularization [64]. Human and murine
studies  have  both  found  that  vitreal  EPO  expression  is
associated with proliferative diabetic retinopathy [65].
Candidates derived using the key terms “oxidative stress”
included several adhesion molecules. ICAM1 is expressed by
endothelial cells and plays a critical role in leukocyte stasis
and migration to the injury site [66]. Dopamine receptor 2 acts
as an antioxidant at physiologic concentrations of dopamine;
it  has  been  found  to  regulate  the  production  of  reactive
oxidative species, and KO mice have higher blood pressure in
part due to the increased oxidative damage in the kidney
[67]. The low-density lipoprotein receptor is also involved in
mediating oxidative stress; KO mouse models have increased
oxidative  stress,  inflammation,  and  atherosclerosis  [68].
Furthermore, oxidative modification of this receptor has been
associated  with  endothelial  cell  dysfunction  [69].  Three
different  cytochrome  P450  genes  were  also  found  to  be
candidates by the Positional Medline program; however, this
may be a spurious result due to the large amount of data
published  regarding  oxidative  stress  generated  in  the
metabolism of various drugs.
The  support  interval  of  the  QTL  on  chromosome  5
associated with weight includes 101 candidate genes related
to “birth weight.” Low maternal serum α-fetoprotein (AFP)
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386levels have been shown in humans to be associated with high
birthweight infants [70]. Heparanase, HPSE, plays a role in
placental development and affects both structure and nutrient
transport [71]. CXCL1, 2, 4, and 10 are chemokines that have
been  studied  extensively  in  regard  to  their  role  in
inflammation [72,73], development [73], angiogenesis [73,
74], and neoplasia [74].
In conclusion, revascularization in OIR is related to the
weight, strain of paternal grandmother, sex, and albinism. Our
data support the existence of a QTL on chromosome 5 that
influences weight after exposure to hyperoxia, as well as QTL
on chromosomes 7 and 9 that modify susceptibility to OIR.
Ongoing  studies  are  investigating  the  role  of  candidate
quantitative trait genes as modifiers of the progression of OIR.
It is hoped that investigation of quantitative trait genes will
help to elucidate the pathogenesis of ROP. These modifier
genes may also be candidates for susceptibility genes in other
complex  ocular  diseases  involving  aberrant  angiogenic
responses, such as diabetic retinopathy and neovascular age-
related macular degeneration.
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